close hamburger search alert

Bitter Melon (generic name)

treats Diabetes mellitus, Human immunodeficiency virus, and Cancer
Table of Contents
powered by healthline

Average Ratings

Alternate Title

Momordica charantia, MAP30, Bitter gourd

Category

Herbs & Supplements

Synonyms

African cucumber, alpha-momorcharin, ampalaya, balsam-apple, Balsambirne (German), balsam pear, balsambirne, balsamo, beta-momorcharin, bitter apple, bitter cucumber, bitter gourd, bittergurke, bitter melon capsules, bitter melon extract, bitter melon juice, bitter melon malt vinegar, bitter melon seed oil, carilla gourd, cerasse, charantin, chinli-chih, cundeamor, Cucurbitaceae (family), fructus momordiaca grosvenori, GlyMordica®, goya, kakara, karavella, karela, kareli, kathilla, kerala, Koimidori bitter melon, kuguazi, K'u-kua, Lai margose, MAP30, Momordica charantia, momordique, pavakkachedi, pepino montero, P'u-t'ao, sorosi, sushavi, vegetable insulin, wild cucumber.

Background

Bitter melon (Momordica charantia L. Curcurbitaceae) has traditionally been used as a remedy for lowering blood sugar in patients with diabetes. Preliminary data exists on bitter melon use in HIV and cancer. Extracts and powdered formulations of the fruit are most frequently used, although teas made from the stems and leaves are sometimes recommended.

Bitter melon is also consumed as a foodstuff and is found as an ingredient in some south Asian curries. The raw fruit is available in specialty Asian markets where it is known as karela.

Evidence

DISCLAIMER: These uses have been tested in humans or animals. Safety and effectiveness have not always been proven. Some of these conditions are potentially serious, and should be evaluated by a qualified healthcare provider.

Cancer: MAP30, a protein isolated from bitter melon extract, has been reported to possess anti-cancer activity, although potential anti-cancer effects have not been studied in humans. Additional study is needed before a strong recommendation can be made.
Grade: C

Diabetes mellitus (hypoglycemic agent): Preliminary study has indicated that bitter melon may decrease serum glucose levels; however, reports are mixed. Because safety and efficacy have not been established, bitter melon should be avoided by diabetics except under the strict supervision of a qualified healthcare professional, including a pharmacist, with careful monitoring of blood sugars.
Grade: C

Human immunodeficiency virus (HIV): Early studies have shown that a protein in bitter melon called MAP30 may have antiviral activity, but this has not been studied in humans. Further research is needed before a strong recommendation can be made.
Grade: C

Tradition

WARNING: DISCLAIMER: The below uses are based on tradition, scientific theories, or limited research. They often have not been thoroughly tested in humans, and safety and effectiveness have not always been proven. Some of these conditions are potentially serious, and should be evaluated by a qualified healthcare provider. There may be other proposed uses that are not listed below.
Abortion, analgesia (pain relief), anorexia, antifungal, antimicrobial, antioxidant, antiparasitic, antitumor, antiviral, chemopreventive, contraception, diabetic neuropathy, disorders of the stomach and intestines (diabetic gastopathy), gastrointestinal cramps, glaucoma, hemorrhoids, herpes, high cholesterol, immunomodulation, infertility, pain, psoriasis, respiratory infections, retinopathy, rheumatoid arthritis, sinusitis, stomach cramps.

Dosing

Adults (over 18 years old)

Due to the wide variations in preparation techniques of bitter melon, the proper dosing cannot be determined at the present time. Bitter melon has sometimes been administered as a fruit juice in doses of 50 milliliters or 100 milliliters in diabetic patients. Juice formulations have been reported to have more potent effects on blood sugar and lab values than the powder of the sun-dried fruit. However, safety and efficacy have not been established for any specific dose(s) of bitter melon.

Subcutaneous administration of bitter melon has been studied in humans, although safety, efficacy, and dosing have not been clearly established.

Children (under 18 years old)

There is not enough scientific data to recommend bitter melon for use in children. Caution is advised, based on two case reports of hypoglycemic coma in children following the ingestion of bitter melon tea.

Safety

DISCLAIMER: Many complementary techniques are practiced by healthcare professionals with formal training, in accordance with the standards of national organizations. However, this is not universally the case, and adverse effects are possible. Due to limited research, in some cases only limited safety information is available.

Allergies

Individuals with allergies to plants related to the bitter melon or members of the Curcurbitaceae (gourd or melon) family, including Persian melon, honeydew, casaba, muskmelon, and cantaloupe, may have allergic reactions to bitter melon.

Side Effects and Warnings

Headaches have been reported after the ingestion of bitter melon seeds. However, details regarding severity and duration of headaches are limited. Considerable rises in liver enzymes have been observed in animals after drinking bitter melon fruit juice and seed extract. These rises, however, have not been associated with significant damage or changes in the liver. The clinical relevance in humans has not been studied, so caution is advised, particularly in patients with underlying liver disease. The seeds and outer-rind of bitter melon contain a toxic chemical (lectin), which inhibits protein synthesis in the intestinal wall. Although this has not been correlated with signs or symptoms in humans, ingestion of bitter melon seeds or outer rind should be avoided due to potential adverse effects.

Bitter melon may lower blood sugar levels. Caution is advised in patients with diabetes or hypoglycemia (low blood sugar) and in those taking drugs, herbs, or supplements that affect blood sugar. Serum glucose levels may need to be monitored by a healthcare provider, and medication adjustments may be necessary. Two case reports have documented hypoglycemic coma and convulsions in children after the administration of a bitter melon tea.

Ingestion of bitter melon (or bitter melon seeds) should be avoided in patients with glucose-6-phosphate dehydrogenase (G6PDH) deficiency, due to the risk of hemolytic reaction and "favism." Favism is the onset of hemolytic anemia with symptoms including headache, fever, stomach pain, and coma. G6PDH deficiency and favism are most common in people from the Mediterranean and the Middle East.

The fertility rate of mice that were fed with daily bitter melon juice dropped from 90% to 20% in one study. Sperm production was inhibited in dogs that were fed a bitter melon fruit extract for 60 days. However, studies of a protein isolated from bitter melon seeds, called MAP30, have found that they do not affect sperm motility in laboratory studies.

Pregnancy and Breastfeeding

Bitter melon is not recommended during pregnancy; two proteins isolated from the raw fruit possess properties that may cause an abortion in animals. Lowered fertility rates are also possible.

Interactions

Interactions with Drugs

Bitter melon may lower blood sugar levels. Caution is advised when using medications that may also lower blood sugar. Patients taking drugs for diabetes by mouth or insulin should be monitored closely by a qualified healthcare professional, including a pharmacist.

Elevations in liver enzymes have been reported. Theoretically, bitter melon may interact with drugs metabolized by or affecting the liver.

The antiviral protein of bitter melon may enhance the therapies of the HIV antagonists, dexamethasone and indomethacin. Bitter melon may have antiviral and immunomodulating effects and therefore may have additive effects with other drugs with similar activity.

Bitter melon leaf extracts have been observed to reverse chemotherapy drug resistance.

Bitter melon may lower triglyceride levels and therefore may have additive effects with other drugs with similar activity.

Absorption, distribution, metabolism, and elimination (pharmacokinetics) of other drugs may be altered by bitter melon.

Bitter melon may induce abortion, reduce fertility rates, or inhibit production of sperm. Caution is advised in patients taking fertility agents or antifertility agents.

In theory, bitter melon may interact with medications used to treat parasites (anthelmintics).

Interactions with Herbs and Dietary Supplements

Bitter melon may lower blood sugar levels. Caution is advised when using herbs or supplements that may also lower blood sugar. Blood sugar levels may require monitoring, and doses may need adjustment.

Elevations in liver enzymes have been reported. Theoretically, bitter melon may interact with drugs metabolized by or affecting the liver.

Bitter melon leaf extracts have been observed to reverse chemotherapy drug resistance.

Bitter melon may lower triglyceride levels and therefore may have additive effects with other drugs with similar activity.

Absorption, distribution, metabolism, and elimination (pharmacokinetics) of other drugs may be altered by bitter melon.

Bitter melon may induce abortion, reduce fertility rates, or inhibit production of sperm. Caution is advised in patients taking herbs or supplements with proposed fertility or antifertility effects.

In theory, bitter melon may also interact with herbs or supplements that suppress or enhance the immune system. Furthermore, bitter melon may interact with medications used to treat parasites (anthelmintics), although human evidence is lacking in this area.

Attribution

This information is based on a systematic review of scientific literature edited and peer-reviewed by contributors to the Natural Standard Research Collaboration (www.naturalstandard.com): Ethan Basch, MD (Memorial Sloan-Kettering Cancer center); Samuel Basch, MD (Mt. Sinai Medical Center); Lisa Cheung, PharmD (University of Rhode Island); Dawn Costa, BA, BS (Natural Standard Research Collaboration); Cathi Dennehy, PharmD (University of California, San Francisco); Steven Gabardi, PharmD (Brigham and Women's Hospital/Northeastern University); Nicole Giese, MS (Natural Standard Research Collaboration); Peter Glickman, MD (Harvard Medical School); Michael Goble, BS, PharmD (Massachusetts College of Pharmacy); Sadaf Hashmi, MD, MPH (Johns Hopkins School of Hygiene and Public Health); David Kroll, PhD (Duke University); Erica Rusie, PharmD (Natural Standard Research Collaboration); Michael Smith, MRPharmS, ND (Canadian College of Naturopathic Medicine); David Sollars, MAc, HMC (New England School of Acupuncture); Philippe Szapary, MD (University of Pennsylvania); Shaina Tanguay-Colucci, BS (Natural Standard Research Collaboration); Catherine Ulbricht, PharmD (Massachusetts General Hospital); Wendy Weissner, BA (Natural Standard Research Collaboration); Jen Woods, BS (Northeastern University).

Page: < Back 1 2 3 4 Next >
Licensed from
Top of page
General Drug Tools
General Drug Tools
Health Management
Programs
Health Management Programs
Tools for
Healthy Living
Tools for Healthy Living